Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 EUR | +5.73% | +26.98% | +128.57% |
2023 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
2023 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 537K 577K 46.17M | Sales 2022 | 277K 298K 23.86M | Capitalization | 1.7M 1.82M 146M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.07M -85.99M | Net income 2022 | - 0 0 | EV / Sales 2021 | 9 x |
Net Debt 2021 | 1.65M 1.77M 141M | Net Debt 2022 | 2.64M 2.83M 227M | EV / Sales 2022 | 15.6 x |
P/E ratio 2021 |
-3.16
x | P/E ratio 2022 |
-2.11
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | +5.73% | ||
1 week | +26.98% | ||
Current month | +60.00% | ||
1 month | -4.00% | ||
3 months | +98.35% | ||
6 months | +84.62% | ||
Current year | +128.57% |
Managers | Title | Age | Since |
---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 31/12/19 |
Élodie Giroux
COO | Chief Operating Officer | - | 30/06/20 |
Dorian Pierre
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 31/12/19 |
Director/Board Member | 74 | 21/10/20 | |
Director/Board Member | 49 | 28/06/21 |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 0.48 | +5.73% | 100 |
07/05/24 | 0.454 | +16.41% | 100 |
06/05/24 | 0.39 | +3.17% | 102 |
03/05/24 | 0.378 | 0.00% | 0 |
02/05/24 | 0.378 | +26.00% | 96 |
Real-time Euronext Paris, May 08, 2024 at 03:30 pm
More quotes- Stock Market
- Equities
- MLOCT Stock